INTELLIGENCE IN ACTION

HIMSS19 Showed Glimpses of a Bright Future, But Also Problem Solving in the Here and Now

March 25, 2019

Dr. Andrew Mellin, Surescripts VP of Medical Informatics Physician has been to nearly 20 HIMSS conferences over his career, wearing different hats as a physician, as a vendor and as a health system leader. But this one, his first one as a member of the Surescripts team, felt different, as he explained in a recent article on LinkedIn.

“With my many conversations with provider leaders, technology companies, healthcare associations, and entrepreneurs—I felt like I was at the center of something big and impactful, [as Surescripts] is a facilitator that brings together virtually every major stakeholder in healthcare, including arch competitors, with a common goal to improve safety, lower costs and ensure quality care,” says Dr. Mellin.

“To me, the most profound impact the Surescripts Network Alliance will have in the next few years is removing the opaque reality of an individual person’s financial responsibility for a prescription,” he says.

Dr. Mellin had the opportunity to facilitate a panel at the HIMSS Interoperability Showcase, with a focus on the need for, and transformative power of, prescription price transparency at the point of care. The panelists, all participants in the Network Alliance, talked frankly about the very real need for this technology and that it can be a real game changer in the care journey. Not just for the patient, but for the prescriber, as well, which can help alleviate the very real phenomenon of physician burnout, noted a number of the panelists.

“This HIMSS was different for me—it was not about cool technologies and future promises, but it was about solving difficult, industry-wide problems today. The rapid adoption and value realization for prescription price transparency tools is the manifestation of years of work by my colleagues and people across the industry to build a foundation of trust, technology, and standards,” Dr. Mellin says. “And, I’m excited to work across the industry to put this tool in every provider’s hands and to work with the Surescripts Network Alliance to solve the next hard challenge.”

To read Dr. Mellin’s full take on HIMSS19, check out his article on LinkedIn. And for more on Surescripts’ experience at HIMSS19, be sure to view our highlights video

Related Articles

April 15, 2019

Older, Sicker Patients Will Benefit from Real-Time Benefit Tools, So Let’s Not Delay Using Them.

Healthcare costs are increasingly prohibitive for too many Americans, and these costs can hit older Americans especially hard. That’s why we applaud the Centers for Medicare & Medicaid Services (CMS) proposed rule on real-time benefit tools (RTBT). Read more...
March 15, 2019

HIMSS19 Highlights: Five Takeaways from Healthcare Leaders on Prescription Price Transparency

Judging by recent news headlines and my social media feed, this year’s HIMSS gathering seemed to be the most exciting and energized yet—not only because of the many emerging technologies under discussion and on display, but also the overall sense that the industry is making real progress, and positively impacting patient care in some very real ways. And the Surescripts Network Alliance™ led discussions throughout the show that demonstrating this impact through the lens of a very hot topic: prescription price transparency.

Read more...
February 19, 2019

Disrupting the Drug Cost Trajectory: Dr. Michelle Mello on Making Medications Affordable

Prescription drug prices continue to rise, with no end in sight. Americans have complained to their representatives about the rising prices and policymakers are listening. A new Politico-Harvard poll of U.S. adults found that 80 percent of those surveyed said that lowering prescription drug prices should be an “extremely important” priority for the new Congress. Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX